A new AI model from Google DeepMind called AlphaGenome can predict how DNA mutations affect biological processes, helping pinpoint genes linked to diseases and speeding up drug discovery.

It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.

Fixing gene defects with designer DNA is on the horizon after Google DeepMind launched a pioneering new AI tool.

AlphaGenome can analyse up to 1m letters of DNA code at once and could pave way for new treatments ...

Researchers have revealed that so-called ‘junk DNA’ contains powerful switches that help control brain cells linked to Alzheimer’s disease. When people picture DNA, they often imagine a set of genes ...

Cells are defined by the genes they express. In human cells, there are thousands of different protein coding genes, and the expression of those genes is carefully orchestrated and controlled by a ...

Non-coding DNA variants contribute to acute lymphoblastic leukemia (ALL) chemotherapy resistance. St. Jude Children's Research Hospital scientists have identified specific DNA variants in the ...

Researchers from CSIRO, Australia's national science agency, have unlocked the most detailed genetic blueprint yet of a major ...

There are some genes that can promote cancer; they are sometimes called oncogenes, and in tumor cells, mutations are often found in these genes. When they are functioning normally, oncogenes are often ...

Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.